Council of Scientific and Industrial Research (CSIR) Current Affairs, GK & News

“Arogya Path”: Portal to provide health care supply updates launched

The Council of Scientific and Industrial Research National Health Supply Chain portal called “Arogya Path” was launched to provide real-time availability of health care supplies. Highlights The Arogya path will serve suppliers, manufacturers and customers. It will act as an integrated platform to provide information about key health care goods that help customers to tackle ..

Month: 

Category: 

Topics: 

India finds a tool to get deeper insight into Parkinson’s Disease

The Scientists of IIT Dhanbad and CSIR (Council of Scientific and Industrial Research) have teamed up together to find a major cause of Parkinson’s disease a solution. Key Findings Parkinson’s disease is a neurodegenerative disease and so far, no cure has been found to heal the disease. The researchers of these institutes have found a ..

Month: 

Category: 

Topics: 

CSIR Technology of Electrostatic Disinfection transferred for Commercialization

The Council of Scientific and Industrial Research – Central Scientific Instrument Organization (CSIR-CSIO) has developed a technology for sanitization and effective disinfection. The CSIR-CSIO has transferred the technology to a Nagpur based company Rite Water Solutions Private Limited. Highlights The Disinfectant technology has been found to be highly effective and efficient to stop the spread ..

Month: 

Category: 

Topics: 

Feluda: COVID-19 test developed by CSIR-IGIB scientists

The IGIB (Institute of Genomics and Integrative Biology) operating under CSIR (Council of Scientific and Industrial Research) have come up with a COVID-19 test called “Feluda”. Highlights The test has been named after a detective character in the stories of film maker Satyajit Ray. The total time taken by the test to produce results is ..

Month: 

Category: 

Topics: 

DCGI approves COVID-19 drug to reduce mortality rate

On April 20, 2020, the Drugs Controller General of India (DCGI) approved trial of a drug to reduce mortality rate of COVID-19 patients. Highlights The COVID-19 drug that was developed by the Cadila Pharmaceuticals along with Council of Scientific and Industrial Research (CSIR) is to enter into trial. The clinical trial has been approved by ..

Month: 

Category: 

Topics: 

1 / 3123